After K Natwar Singh was stripped of the external affairs ministry portfolio, the focus is now on the evidence against him and the Congress party, which was also named as one of the non-contractual......
In a setback to Sun Pharma-Ranbaxy merger process, Andhra Pradesh High Court has issued orders to Bombay Stock Exchange and National Stock Exchange to maintain interim status quo on the......
The $4-billion merger of Ranbaxy Labs with Sun Pharmaceutical has got clearance from the two leading stock exchanges – Bombay Stock Exchange and National Stock Exchange. The 'no-objection'......
Israel Makov, the 75-year-old chairman of Sun Pharmaceutical, pushed through the deal to acquire Ranbaxy at a six-hour board meeting on Sunday. Makov’s contribution was not limited to......
The capital markets regulator, Securities and Exchange Board of India, is likely to begin a preliminary inquiry into the $4-billion merger deal between pharma giants Sun Pharmaceutical and Ranbaxy......
A spokesperson said the objective of Sun Pharma-Ranbaxy merger is to create a larger and better organisation for all its stakeholders. Sun Pharmaceutical Industries has started easing out excess......